Home/Filings/4/0000899243-23-001407
4//SEC Filing

Trost Timothy W. 4

Accession 0000899243-23-001407

CIK 0001785530other

Filed

Jan 8, 7:00 PM ET

Accepted

Jan 9, 9:35 PM ET

Size

10.3 KB

Accession

0000899243-23-001407

Insider Transaction Report

Form 4
Period: 2023-01-03
Trost Timothy W.
Chief Financial Officer
Transactions
  • Award

    Stock Option (right to buy)

    2023-01-03+102,800102,800 total
    Exercise: $2.05Exp: 2032-12-31Common Stock (102,800 underlying)
Footnotes (1)
  • [F1]The option was granted on January 3, 2023 with a Vesting Commencement Date of January 1, 2023. The shares underlying the option vest in equal monthly installments over four years, commencing on the date that is one month following the Vesting Commencement Date and vesting monthly thereafter through January 1, 2027.

Issuer

Werewolf Therapeutics, Inc.

CIK 0001785530

Entity typeother

Related Parties

1
  • filerCIK 0001571865

Filing Metadata

Form type
4
Filed
Jan 8, 7:00 PM ET
Accepted
Jan 9, 9:35 PM ET
Size
10.3 KB